Author

Emanuel F Petricoin

George Mason University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Clint A. StalneckeriD· 1 shared Elyse G. SchechteriD· 1 shared Jonathan M. DeLibertyiD· 1 shared Khalilah E. TayloriD· 1 shared Kirsten L. BryantiD· 1 shared Lily M. PitaiD· 1 shared Mallory K. RoachiD· 1 shared Mariaelena PieroboniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Clint A. StalneckerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Vertical inhibition of the autophagy pathway impairs growth and enhances sensitivity to mTORC1 inhibition in pancreatic ductal adenocarcinoma

Mallory K. Roach, Seamus E. Degan, Jonathan M. DeLiberty, Lily M. Pita, Noah L. Pieper, 杨闰英, Khalilah E. Taylor, Elyse G. Schechter, Ryan N. Robb, Mariaelena Pierobon, Clint A. Stalnecker, Emanuel F Petricoin, Kirsten L. Bryant

This study identifies that vertical inhibition of the autophagy pathway enhances sensitivity to mTORC1 inhibition in PDAC, improving therapeutic efficacy.

bioRxiv · Jun 29, 2026 · PreprintCancer Biology